sRAGE and early signs of cardiac target organ damage in mild hypertensives

BACKGROUND: Soluble Receptor for Advanced Glycation End Products (sRAGE) may be considered a marker inversely related to inflammation and its participation has been established in patients with advanced atherosclerotic vascular diseases. However, it is still unknown whether sRAGE reduction could be...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cardiovasc Diabetol
Autores principales: Maresca, Andrea Maria, Guasti, Luigina, Bozzini, Sara, Mongiardi, Christian, Tandurella, Nicolò, Corso, Rossana, Zerba, Francesco G., Squizzato, Alessandro, Campiotti, Leonardo, Dentali, Francesco, Klersy, Catherine, Grandi, Anna M., Falcone, Colomba
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6371567/
https://ncbi.nlm.nih.gov/pubmed/30755202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0821-5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares